Exelixis, Inc. - Common Stock (NQ:EXEL)Price and VolumeDetailed Quote
Top NewsMore News
Performance
52-Week Range
2.7% below 52-week high
70.13
36.0052W Low
72.1052W High
1 Week
2.7% below 1-week high
64.391W Low
72.101W High
Exelixis, Inc. - Common Stock (EXEL) traded between $36.00 and $72.10 over the past 52 weeks and last traded at $70.13, 2.7% below its 52-week high. Over the past week it ranged between $64.39 and $72.10.
Past 12 Months
+7.3%
+19.2%
+27.4%
+58.8%
+60.9%
+84.3%
1W
+$4.78
1M
+$11.28
3M
+$15.07
6M
+$25.96
YTD
+$26.55
1Y
+$32.07
EXEL was +84.3% over the past year, +58.8% over six months, +60.9% year to date, +7.3% in the last week.
12 Months vs Market
EXEL
DIA
SPY
QQQ
IWM
Over the past 12 months EXEL returned +84.3% versus DIA (Dow) +9.7%, SPY (S&P 500) +10.1%, QQQ (Nasdaq 100) +7.8% and IWM (Russell 2000) +13.7%.
Volume & Liquidity
0.00× 3-mo avg
Today 684
3-mo avg 2.4M
1W
1M
3M
6M
YTD
1Y
EXEL most recently traded 684 shares against a 3-month average daily volume of 2.4M. More NewsRead More
Exelixis Announces Third Quarter 2026 Financial Results and Provides Corporate Update
October 29, 2026
From Exelixis, Inc.
Via Business Wire
Via Chartmill
Via Chartmill
Via Chartmill
Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock ↗
October 26, 2026
Via MarketBeat
Topics
Intellectual Property
Forget the FDA Delay: 3 Reasons Exelixis Is Still a Buy ↗
October 24, 2026
Via The Motley Fool
Exelixis Eyes Oncology Deals, Readies Zanzalintinib Launch as Cabozantinib Tops $3B ↗
September 17, 2026
Via MarketBeat
Topics
Artificial Intelligence
Exelixis Eyes Zanza Launch as CABOMETYX Growth Faces NET Ramp Hurdle ↗
September 15, 2026
Via MarketBeat
Exelixis Eyes CABOMETYX Growth, Zanzalintinib Catalysts Across Cancer Franchises ↗
September 14, 2026
Via MarketBeat
Topics
Artificial Intelligence
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September
September 01, 2026
From Exelixis, Inc.
Via Business Wire
From Exelixis, Inc.
Via Business Wire
Exelixis (EXEL) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Via The Motley Fool
Topics
Earnings
Exelixis Q2 Earnings Call Highlights ↗
August 05, 2026
Via MarketBeat
Topics
Earnings
3 Under-the-Radar Stocks to Buy and Hold ↗
July 10, 2026
Via The Motley Fool
Frequently Asked QuestionsIs Exelixis, Inc. - Common Stock publicly traded?
Yes, Exelixis, Inc. - Common Stock is publicly traded.
What exchange does Exelixis, Inc. - Common Stock trade on?
Exelixis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exelixis, Inc. - Common Stock?
The ticker symbol for Exelixis, Inc. - Common Stock is EXEL on the Nasdaq Stock Market
What is the current price of Exelixis, Inc. - Common Stock?
The current price of Exelixis, Inc. - Common Stock is 70.13
When was Exelixis, Inc. - Common Stock last traded?
The last trade of Exelixis, Inc. - Common Stock was at 11/02/26 04:00 PM ET
What is the market capitalization of Exelixis, Inc. - Common Stock?
The market capitalization of Exelixis, Inc. - Common Stock is 22.09B
How many shares of Exelixis, Inc. - Common Stock are outstanding?
Exelixis, Inc. - Common Stock has 22B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>